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PARTIAL AND SELECTIVE INACTIVATION OF THROMBOKINASE BY CHYMOTRYPSINt
Thrombokinase has been isolated from bovine plasma in a form that ap-
proached electrophoretic homogeneity` and gave a single boundary in the
ultracentrifuge.' Such material has four separately measurable activities: 1.
activation of prothrombin in the presence of oxalate; 2. activation of pro-
thrombin in the presence of ionic calcium, phospholipid and factor V; 3.
activation of chymotrypsinogen; and 4. hydrolysis of tosylarginine methyl
ester. The defining property has been taken as the direct, unaided activation
of prothrombin, which can be assayed, with thrombokinase. in microgram
concentrations. However, thrombokinase can be assayed in nanogram con-
centrations, provided that the prothrombin is accompanied by ionic calcium,
phospholipid and factor V. It is this latter property which has now been
preferentially destroyed by chymotrypsin. Moreover, this has been accom-
panied by a molecular change in the thrombokinase.
Such selective inactivation has not heretofore been described for throm-
bokinase, or for apparently equivalent factors, such as activated factor X
and autoprothrombin C. However, a similar molecular variant has now also
been found in some preparations of thrombokinase to which no chymotrypsin
had been added.
MATERIALS AND METHODS
Step-7 thrombokinase. Thrombokinase purified from bovine plasma and put through
all steps of the isolation procedure, except the last.' It had been chromatographed on
DEAE-cellulose; but it had not been fractionated electrophoretically.
Veronal-buffered saline. 0.9 percent NaCl: 0.02M Veronal, pH 7.4.'
Chymotrypsin. a-Chymotrypsin, 3x crystallized from the activation product of 3x
crystallized chymotrypsinogen. Dialyzed salt free, lyophilized. Worthington Biochemical
Corporation, Freehold, N.J.
Chymotrypsinogen. For assay of activator. Chymotrypsinogen A, 5x crystallized,
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chromatographically homogeneous. Supplied salt free by Worthington Biochemical
Corporation.
TAMe. p-Tosyl-L-Arginine Methylester HCl. Paper Chr: Homogeneous. Mann Re-
search Laboratories, New York, N.Y.
Sephadex. Sephadex Superfine G-100. Particle Size 10-40,u. Lot No. 7941 Pharmacia
Fine Chemicals, Inc., Piscataway, N.J.
Blue Dextran. Blue Dextran 2000. Mw Approx. 2,000,000. Pharmacia Fine Chemicals,
Inc.
Chymotrypsinogen. For gel filtration. Chymotrypsinogen A, 3x crystallized from
ammonium sulfate and finally salt free from ethanol. Worthington Biochemical Cor-
poration.
Egg albumin. Crystallized and lyophilized salt free. Grade V. Electrophoretic purity,
approximately 99 percent. Sigma Chemical Co., St. Louis, Mo.
Bovine plasma albumin. Crystallized bovine plasma albumin. Armour Pharmaceutical
Co., Kankakee, Ill.
Coagulation tests. As described.'
Working assay. Essentially as described."5 The five-reagent thrombin-producing mix-
ture contained 0.5 ml. prothrombin (35 units), 0.1 ml. phospholipid, 02 ml. factor V,
0.1 ml. calcium chloride and 0.1 ml. of the thrombokinase to be assayed. Activity was
expressed as relative to a standard thrombokinase, which was tested in parallel, in the
same system. A relative activity of 100 would mean that the unknown, at a dilution of
1:200,000 caused the system to produce thrombin as fast as the standard thrombokinase
at a dilution of 1:2,000.
Thrombokinase (Kinase). Unaided activation of prothrombin in the presence of
oxalate. This thrombin-producing mixture was composed of 0.8 ml. prothrombin (212
units), 0.1 ml. O.1M potassium oxalate and 0.1 ml. of the solution to be assayed for
thrombokinase. The number of NIH units of thrombin produced in one hour at 28°C.
by this mixture was taken as the titer of the solution. This was then multiplied by the
dilution of the unknown in the solution that was assayed, if such a dilution had been
made.
Chymotrypsinogen activator. As described.'
Esterase activity on TAMe. Method of Sherry and Troll' with minor modifications.'
Optical density. Measured with a spectrophotometer at 280 nanometers. Values plotted
in the Figures were those obtained after subtraction of a blank for veronal-buffered
saline.
Estimation of protein. Method of Lowry, et al.,' with electrophoretically isolated
thrombokinase as standard.
Ultrafiltration. With Amicon Cell 401, Diaflo Membrane UM-10 at 55 psi. Amicon
Corporation, Lexington, Mass.
Gel filtration. Although the initial experiments were done with regular Sephadex
G-100, all experiments herein reported were done on the same column of superfine
Sephadex G-100. The ratio of elution volume to void volume for bovine albumin on
regular Sephadex G-100 was about the same as that reported by Whitaker;' but when
superfine Sephadex G-100 was used, the ratio was significantly smaller. Elution curves
were sharper, and resolution was better with the superfine Sephadex. The use of super-
fine Sephadex in columns was suggested by Frederick G. Kalfon, technical representa-
tive of Pharmacia Fine Chemicals, Inc.
Thirty grams superfine Sephadex was stirred into 1,400 ml. distilled water and diluted
to 1,900 ml. After the suspension had settled for half an hour, the supernatant fluid,
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with some fine particles still suspended, was removed by aspiration. The thick suspen-
sion was stirred with veronal-buffered saline, allowed to settle again; and the super-
natant fluid was removed. Dilution with fresh buffer, stirring, settling and removal of
supernatant fluid were repeated five times. The thick suspension was then transferred to
a flask; and 100 ml. veronal-buffered saline was used to wash residual suspension into
the flask. The final suspension was kept at 4-8'C. for one month.
A column of superfine Sephadex G-100, approximately 2.5 x 40 cm. was poured in
a Sephadex K 25/45 glass laboratory column, set up in a large, glass-doored refrig-
erator at 4-5'C. Column flow was downward. A sample applicator was placed on top
of the gel; and a Mariotte flask with veronal-buffered saline was connected to the top
of the column by a length of tubing. The column was allowed to flow for two days,
during which the Mariotte flask was adjusted to maintain a hydrostatic pressure of
11 cm. and a flow-rate of about 10 ml. per hour. Every sample was in veronal-buffered
saline; and 1.0 ml. was introduced from a cold tuberculin syringe fitted with a long
needle bent at a right angle near its tip. This made it easier to layer the sample be-
neath the buffer at the bottom of the sample applicator. Collection of 102-drop frac-
tions was begun when 17 small drops (0.5 ml.) had emerged from the outflow tubing,
i.e. when about half the sample had entered the column.'0 At the end of the run, the
volume of each fraction was measured in a graduate, and found to be close to 3.0 ml.
The dead space at the bottom of the column and in the outflow tubing had been de-
termined to be 0.6 ml.; and it was subtracted from the outflow volume. In charting the
data, the points were placed at the volume representing the middle of the fractions.
For elution volumes, mid-points of the peaks were estimated on the charts, to the near-
est 0.1 ml.
RESULTS
The first suggestion of selective inactivation revealed itself as considera-
tion was given to the activation of chymotrypsinogen by thrombokinase.
The fact that activation continued long after active chymotrypsin was
demonstrable' indicated that the activator must be somewhat resistant to
chymotrypsin. However, the working assay showed that considerable ac-
tivity was rapidly lost in the presence of less than one microgram of
chymotrypsin per ml., a concentration exceeded in most activation experi-
ments. On the other hand, preliminary tests showed that the capacity to
activate chymotrypsinogen was retained, as was the capacity to activate
prothrombin in the presence of oxalate.
Another suggestion of selective inactivation appeared when a preparation
of human thrombokinase was tested for Dr. D. L. Aronson of the National
Institutes of Health. It was strong when tested in the oxalated system; but
relatively weak in the working assay. At that time Aronson and Menache
had already encountered molecular variants of prothrombin;U and the pos-
sibility of a molecular variant of thrombokinase was considered. Since then,
Dr. Aronson has indicated (personal communication) that variable propor-
tions of such a variant appear to be present in his preparations of human
thrombokinase.
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In a previous study,1' gel filtration of thrombokinase failed to separate
activities associated with thrombokinase; and results with recent gel filtra-
tions have been similar when fresher preparations have been analyzed. With
some older preparations of thrombokinase, however, gel filtration has yielded
some evidence of separation. This is illustrated in Figure IA.
Step-7 thrombokinase, which had been stored for 53 months at -23'C, was con-
centrated by precipitation with ammonium sulfate1' and dialyzed against veronal-buf-
fered saline. It then had 1523 TAMe units and 5.9 mg. protein per ml.; and it was
stored at -23'C. For the experiment of Figure IA it was thawed, and a portion was
mixed with 1/9 volume of veronal-buffered saline. After the mixture was chilled, 1.0
ml. was introduced into the cold column of Sephadex, superfine G-100. The gel was
39.7 cm. high; and a hydrostatic pressure of 11 cm. gave a flow-rate of 8.5 ml. per
hour. Fractions of 3.0 ml. were collected automatically by counting 102 small drops per
fraction.
In Figure IA, it can be seen that the principal protein peak occurs in the
same fraction as the three activity peaks. The protein peak has a shoulder
on the trailing side. Under this shoulder the activity curves for kinase and
esterase tend to follow the protein curve; and they cross over the working-
assay curve, which falls without a shoulder. Beyond the crossing, the ratio
of kinase to working assay is higher than before the crossing. It is the
shoulder that might represent a molecular variant of thrombokinase.
Two days later, the same concentrated thrombokinase was thawed; and a portion
was mixed with 1/9 volume of chymotrypsin in 0.001N HCI. The concentration of
chymotrypsin was one microgram per milliliter of mixture. Samples were taken at 2
minutes and 82 minutes for activity tests. Incubation during this interval was at 30'C.
Then the mixture was chilled 15 minutes in an ice bath and 60 minutes at 4.5°C.; and
1.0 ml. was introduced into the same column as that used for Figure IA. Other than
the chilling and the column fractionation in the cold, nothing was done to stop the ac-
tion of chymotrypsin on thrombokinase. The gel column was 39.6 cm. high; and a
hydrostatic pressure of 11 cm. gave a flow-rate of 8.5 ml. per hour. Fractions of 3.0 ml.
were collected automatically by counting 102 small drops per fraction.
Table 1 summarizes the results of the activity tests on thrombokinase
after incubation with chymotrypsin, but before gel filtration. In 80 minutes
with chymotrypsin at 30°C, 81%o of the activity as measured by the work-
ing assay was lost; but only 12%o of thrombokinase as measured by activa-
tion of prothrombin in the presence of oxalate was lost. Losses of chymo-
trypsinogen activator and esterase were likewise small.
Figure 1B depicts the gel filtration of the chymotrypsin-treated thrombo-
kinase. There it is seen that most of the protein emerged from the column in
the position formerly occupied by the shoulder of Figure 1A; and there is
now only a little protein in the position formerly occupied by the protein
peak. In contrast, the curve for the activity measured by the working assay,
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TABLE 1. INCUBATION OF THROMBOKINASE WITH ONE MICROGRAM CHYMOTRYPSIN
PER MILLITER, AT 30'C.
Percent loss of
Assay value at activity in
Assay system 2 minutes 82minutes 80 minutes
Five-reagent working assay 3800 740 81
Thrombokinase on oxalated prothrombin 549 481 12
Chymotrypsinogen activator 1602 1401 13
Esterase activity on TAMe 1285 1200 7
See section on MATERIALS AND METHODS for details of assays.
although now much lower, is in about the same position as that occupied
by the corresponding curve of Figure 1A. It has become much smaller, but
has not shifted its position, whereas the other activity curves have taken
new positions in parallel with the new protein peak, but they have not be-
come much smaller. Meanwhile, barely perceptible rises in Figure IA have
become definite humps at 120 and 138 ml. in Figure 1B. Conceivably, they
represent smaller fragments produced by the action of chymotrypsin. There
has been less change in the large-particle material that has emerged from
both columns immediately after the void volume at 73 ml. The concentration
of chymotrypsin as protein was so minute that it would not contribute
directly and significantly to the optical density of any effluent fractions in
which it emerged.
The foregoing experiments indicate that amolecular modification occurred
in the thrombokinase as a result of treatment with chymotrypsin and that
there was a concomitant selective loss of activity. They further suggest that
a similar variant thrombokinase occurs in some preparations to which no
enzyme has been added. In Figure 1A, this is represented by a shoulder on
the protein peak. In the most extreme case encountered so far, enough
molecular variant to give another peak has been present "spontaneously."
This is shown in Figure 2.
Step-7 thrombokinase, which had been stored for 52 months at -23°C, was thawed,
concentrated by ultrafiltration and dialyzed against veronal-buffered saline. It then had
2800 TAMe units and 10.2 mg. protein per ml.; and it was stored at -23°C. For- the
experiment of Figure 2, it was thawed, and a portion was mixed with 1/9 volume of
veronal-buffered saline. After the mixture was chilled, 1.0 ml. was introduced into the
column of Sephadex, superfine G-100 at 4.5°C. The gel was 39.7 cm. high; and a hydro-
static pressure of 11 cm. gave a flow-rate of 9.0 ml. per hour. Fractions of 3.0 ml.
were collected automatically by counting 102 small drops per fraction. This experiment
was marred by the occurrence of considerable foaming during ultrafiltration and by a
power failure which made it necessary to stop the column flow for 45 minutes. How-
ever, an uninterrupted run on another sample of the same preparation, which had not
been concentrated or foamed, gave a similar separation of two peaks.
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Figure 2 shows the occurrence of two peaks, of which the first corre-
sponds to that of Figure 1A and the second has a position close to that of
Figure 1B. Most of the activity measured by the working assay is associated
with the first peak, whereas kinase and esterase are divided almost equally
between the two peaks.
The selective separation of activities was such that the ratio of working
assay to thrombokinase was 29 times as great at 91 ml. as it was at 100 ml.
Tests for thrombokinase in the presence of oxalate were done with each
fraction at a final dilution of 1 :50; and the activity was about the same in
the two fractions. However, in the working assay, the fraction at 91 ml. was
tested at a dilution of 1 :1,000,000; whereas the fraction at 100 ml. had about
the same activity at a dilution of 1:30,000. Although the working assay was
thus only 3%o as great at 100 ml. as at peak level, activity was still demon-
strable at high dilution because of the sensitivity of the test. Nevertheless,
the 3%o level might merely represent spreading at the base of the first peak.
How much of this activity actually belongs to the thrombokinase of the
second peak cannot be decided on the basis of present data. Nor can it be
determined whether there is an intermediate series of variants.
The basis for the "spontaneous" occurrence of variant thrombokinase is
not clear. The age of the preparation may not be the most important deter-
mining factor. Variant thrombokinase has also been found in fresher ma-
terial that had been prepared by a modified procedure. And there has not
been enough experience to determine how free of variants an aged prepara-
tion can be. Nor is it known how closely the variant occurring "spontane-
ously" resembles that produced by chymotrypsin.
In separate runs on the same column of Sephadex, elution volumes for
chymotrypsinogen A, egg albumin and bovine plasma albumin were deter-
mined to be 113.6, 95.6 and 85.5 ml., respectively. The void volume was
found to be 73.2 ml. in runs made with Blue Dextran. These data are plotted
according to the method of Whitaker' in Figure 3. There it is seen that
there is a linear relation between molecular weight and ratio of elution
volume to void volume for the three reference proteins, which are taken to
have molecular weights of 25,000, 45,000 and 65,000, respectively.
The elution volumes for the different forms of thrombokinase could be
estimated with varying degrees of accuracy. In Figure 1A, Figure 1B and
Figure 2, the elution volumes of the first peak were 89.5, 89.8 and 89.5 ml.,
respectively. After treatment with chymotrypsin, the elution volume of the
predominant protein was 96.6 ml., as seen in Figure 1B. The variant
thrombokinase in old preparations had elution volumes of 97.0 and 97.1 ml.,
as seen in Figure 1A and Figure 2, respectively. The arrows in Figure 3
indicate where the corresponding ratios would fall on the reference line. Ac-
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cording to this, thrombokinase-emerged from the column in the position
characteristic of "typical proteins" of molecular weight about 56,000. After
treatment with.chymotrypsin, its position corresponded to that of "typical
proteins" of molecular weight about 44,000; and the variant occurring
"spontaneously". was, in this respect, close to that produced by chymo-
trypsin.
DISCUSSION
The isolation of thrombokinase was first described in 1960.-However,
there was no analysis in the ultracentrifuge. Rather, the evidence of isola-
tion was the close approach to electrophoretic homogeneity and the un-
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FIG. 3. Gel filtration behavior of thrombokinase compared with that of "typical pro-
teins." Ve = Elution volume. V. = Void volume. CHTG = Chymotrypsinogen A.
EA = Egg albumin. BPA = Bovine plasma albumin. TK = Thrombokinase. TK' =
Variant thrombokinase.
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usually high clotting activity. Moreover, as later detailed,' there was in the
case of the first isolation a constant specific activity, within experimental
error, across the electrophoretic peak. During the course of repeated electro-
phoretic fractionations, it had been demonstrated that thrombokinase had
the capacity to hydrolyze TAMe; and the specific activities were reported
in terms of this reaction. It was then found' that thrombokinase was one of
the last proteins to be eluted from DEAE-cellulose; and chromatography on
DEAE-cellulore was substituted for the first two of the three electrophoretic
fractionations. The isolation procedure then ended with chromatography on
DEAE-cellulose followed by paper curtain electrophoresis. This material
had the same TAMe esterase activity, within experimental error, as pre-
viously reported; and it gave a single boundary in the analytical ultracentri-
fuge.' However, no estimate of molecular weight was published.
Esnouf and Williams first reported the isolation of bovine factor X in
1961.' They remarked on the striking parallel between the factor X-activated
factor X and the prothrombokinase-thrombokinase systems, and noted the
similar behavior on DEAE-cellulose. Since then, it has been widely con-
sidered probable that factor X is the equivalent of prothrombokinase. On
the basis of sedimentation and diffusion data, Esnouf and Williams estimated
the molecular weight of plasma factor X to be 86,000. They also obtained
factor X from bovine serum, apparently still in the precursor form, and re-
ported it to have a molecular weight of 36,000. Recently, large-scale purifi-
cation of bovine factor X has been described by Jackson, Johnson, and
Hanahan.' This material has been reported to have a molecular weight
about 55,000 by Jackson and Hanahan,ls who also described two kinds of
active molecular variants, detectable by disc electrophoresis and chromatog-
raphy, respectively. They further considered the possibility of an inactive
factor X, electrophoretically indistinguishable from the active species. The
apparent molecular weight (size) by gel filtration on Sephadex G-100 was
given as 80,000-90,000, with distinguishable variants within this range. The
gross difference of this range from the molecular weight determined by
Jackson and Hanahan from sedimentation equilibrium data was ascribed by
them to the asymmetry of the factor X protein, which led to "atypical" be-
havior on gel filtration. Regardless of the reasons for the diversity in the
other estimates of molecular weight, it is quite clear that molecular variants
of factor X do exist.
The precursor molecule can be activated through proteolysis by Russell's
viper venom or trypsin, and apparently becomes smaller in the process.'
It is generally supposed, but not proven, that physiologic activators function
similarly. Seegers, Cole, Harmison, and Marciniak' have suggested that the
order of magnitude for the molecular weight of autoprothrombin C is about
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24,000. However, it has been recognized that although thrombokinase, auto-
prothrombin C and activated factor X activities may appear to be equivalent,
the molecules possessing these common biologic activities as one of their
properties may not be identical.'
The present findings emphasize that thrombokinase can vary not only in
its physico-chemical properties, but also in the proportion of its variously
measured activities. It is of especial interest that the activity destroyed
preferentially by chymotrypsin was that measured by the working assay, i.e.,
the one in which ionic calcium, phospholipid and factor V were added, and
thus the one most like the assays more recently used for activated factor X
and autoprothrombin C. This selective loss was accompanied by a change in
gel filtration properties, which may in turn reflect a change in structure or
conformation. How complete the loss was, and whether it occurred all at
once or in stepwise fashion, are some of the questions remaining for the
future.
Treatment with chymotrypsin is one way of bringing about such a molecu-
lar change in thrombokinase. When a comparable variant occurs in throm-
bokinase to which no chymotrypsin has been added, the possible action of
naturally-occurring enzymes must be considered, as well as non-enzymatic
changes. For this question, the data are as yet insufficient to support a
decision.
SUMMARY
Thrombokinase, prepared from bovine plasma, was incubated with a
minute amount of chymotrypsin. It thereupon lost most of its activity in the
assay with prothrombin, calcium chloride, phospholipid, and factor V. How-
ever, it retained most of its activity in three other assays: 1. activation of
prothrombin in the presence of oxalate, 2. activation of chymotrypsinogen,
and 3. hydrolysis of tosylarginine methyl ester. Such treated thrombokinase
emerged from a gel filtration column in the position characteristic of "typical
proteins" of molecular weight of about 44,000, whereas before treatment
with chymotrypsin it had emerged in the position characteristic of "typical
proteins" of molecular weight about 56,000. While there is thus evidence of
some molecular change, no conclusions are drawn about the molecular
weights of the different forms of thrombokinase, since they may not be
"typical proteins" with respect to gel filtration. Protein similar to that of
treated thrombokinase in behavior on gel filtration and in activity tests, was
found along with the principal protein in some thrombokinase preparations
to which no chymotrypsin had been added.
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NOTE ADDED IN PROOF. Since this paper was submitted for publication, it was
learned that the essential discovery has been made independently by Dr. D. L. Aronson.
In August, 1970, it was announced at the International Congress of Haematology in
Munich. The abstract for this appears on p. 311 of the Abstract Volume: "Two Forms
of the Human Prothrombin Converting Enzyme (Factor Xa)" by D. L. Aronson and
A. J. Mustafa. A longer account has been submitted for publication in Proc. Soc. exp.
Biol. (N.Y.).
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